NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Nov 12 2022

· Issued by NATCO Pharma Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

The company asserts that it believes the lawsuit brought by Walgreens Co. is without merit. Teva is identified as the ANDA holder and marketing partner for the generic product in the US.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

NATCO Pharma Limited on 6ix

In the deck

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases